The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Immunoglobulins Market Research Report 2025
Synopsis
Immunoglobulin’s also called as antibodies are large Y-shaped protein produced by B-cell. These are the glycoprotein molecule produced by plasma cells in response to entry of foreign entity such as bacteria and viruses in the body. Production of antibodies is an important function of immune system. Antibodies use binding mechanism for neutralizing the activity of a foreign particle called as an antigen.
The global Immunoglobulins market was valued at US$ 10450 million in 2023 and is anticipated to reach US$ 13870 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
North American market for Immunoglobulins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Immunoglobulins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Immunoglobulins include Hualan Biological Engineering Inc., Omrix Biopharmaceuticals Ltd., Behring GmbH, Shanghai RAAS Blood Products, Option Care Enterprises, ADMA Biologics, and BioScrip, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Immunoglobulins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunoglobulins.
Report Scope
The Immunoglobulins market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immunoglobulins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immunoglobulins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hualan Biological Engineering Inc.
Omrix Biopharmaceuticals Ltd.
Behring GmbH
Shanghai RAAS Blood Products
Option Care Enterprises
ADMA Biologics,
BioScrip
Segment by Type
IgG
IgA
IgM
IgE
IgD
Segment by Application
Hospital
Research
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Immunoglobulins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Immunoglobulins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Immunoglobulin’s also called as antibodies are large Y-shaped protein produced by B-cell. These are the glycoprotein molecule produced by plasma cells in response to entry of foreign entity such as bacteria and viruses in the body. Production of antibodies is an important function of immune system. Antibodies use binding mechanism for neutralizing the activity of a foreign particle called as an antigen.
The global Immunoglobulins market was valued at US$ 10450 million in 2023 and is anticipated to reach US$ 13870 million by 2030, witnessing a CAGR of 4.1% during the forecast period 2024-2030.
North American market for Immunoglobulins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Immunoglobulins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Immunoglobulins include Hualan Biological Engineering Inc., Omrix Biopharmaceuticals Ltd., Behring GmbH, Shanghai RAAS Blood Products, Option Care Enterprises, ADMA Biologics, and BioScrip, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Immunoglobulins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunoglobulins.
Report Scope
The Immunoglobulins market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immunoglobulins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immunoglobulins manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hualan Biological Engineering Inc.
Omrix Biopharmaceuticals Ltd.
Behring GmbH
Shanghai RAAS Blood Products
Option Care Enterprises
ADMA Biologics,
BioScrip
Segment by Type
IgG
IgA
IgM
IgE
IgD
Segment by Application
Hospital
Research
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Immunoglobulins manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Immunoglobulins in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Immunoglobulins Market Overview
1.1 Product Overview and Scope of Immunoglobulins
1.2 Immunoglobulins Segment by Type
1.2.1 Global Immunoglobulins Market Value Comparison by Type (2024-2030)
1.2.2 IgG
1.2.3 IgA
1.2.4 IgM
1.2.5 IgE
1.2.6 IgD
1.3 Immunoglobulins Segment by Application
1.3.1 Global Immunoglobulins Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Research
1.4 Global Immunoglobulins Market Size Estimates and Forecasts
1.4.1 Global Immunoglobulins Revenue 2019-2030
1.4.2 Global Immunoglobulins Sales 2019-2030
1.4.3 Global Immunoglobulins Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Immunoglobulins Market Competition by Manufacturers
2.1 Global Immunoglobulins Sales Market Share by Manufacturers (2019-2024)
2.2 Global Immunoglobulins Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Immunoglobulins Average Price by Manufacturers (2019-2024)
2.4 Global Immunoglobulins Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Immunoglobulins, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Immunoglobulins, Product Type & Application
2.7 Immunoglobulins Market Competitive Situation and Trends
2.7.1 Immunoglobulins Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Immunoglobulins Players Market Share by Revenue
2.7.3 Global Immunoglobulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Immunoglobulins Retrospective Market Scenario by Region
3.1 Global Immunoglobulins Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Immunoglobulins Global Immunoglobulins Sales by Region: 2019-2030
3.2.1 Global Immunoglobulins Sales by Region: 2019-2024
3.2.2 Global Immunoglobulins Sales by Region: 2025-2030
3.3 Global Immunoglobulins Global Immunoglobulins Revenue by Region: 2019-2030
3.3.1 Global Immunoglobulins Revenue by Region: 2019-2024
3.3.2 Global Immunoglobulins Revenue by Region: 2025-2030
3.4 North America Immunoglobulins Market Facts & Figures by Country
3.4.1 North America Immunoglobulins Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Immunoglobulins Sales by Country (2019-2030)
3.4.3 North America Immunoglobulins Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Immunoglobulins Market Facts & Figures by Country
3.5.1 Europe Immunoglobulins Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Immunoglobulins Sales by Country (2019-2030)
3.5.3 Europe Immunoglobulins Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Immunoglobulins Market Facts & Figures by Country
3.6.1 Asia Pacific Immunoglobulins Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Immunoglobulins Sales by Country (2019-2030)
3.6.3 Asia Pacific Immunoglobulins Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Immunoglobulins Market Facts & Figures by Country
3.7.1 Latin America Immunoglobulins Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Immunoglobulins Sales by Country (2019-2030)
3.7.3 Latin America Immunoglobulins Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Immunoglobulins Market Facts & Figures by Country
3.8.1 Middle East and Africa Immunoglobulins Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Immunoglobulins Sales by Country (2019-2030)
3.8.3 Middle East and Africa Immunoglobulins Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Immunoglobulins Sales by Type (2019-2030)
4.1.1 Global Immunoglobulins Sales by Type (2019-2024)
4.1.2 Global Immunoglobulins Sales by Type (2025-2030)
4.1.3 Global Immunoglobulins Sales Market Share by Type (2019-2030)
4.2 Global Immunoglobulins Revenue by Type (2019-2030)
4.2.1 Global Immunoglobulins Revenue by Type (2019-2024)
4.2.2 Global Immunoglobulins Revenue by Type (2025-2030)
4.2.3 Global Immunoglobulins Revenue Market Share by Type (2019-2030)
4.3 Global Immunoglobulins Price by Type (2019-2030)
5 Segment by Application
5.1 Global Immunoglobulins Sales by Application (2019-2030)
5.1.1 Global Immunoglobulins Sales by Application (2019-2024)
5.1.2 Global Immunoglobulins Sales by Application (2025-2030)
5.1.3 Global Immunoglobulins Sales Market Share by Application (2019-2030)
5.2 Global Immunoglobulins Revenue by Application (2019-2030)
5.2.1 Global Immunoglobulins Revenue by Application (2019-2024)
5.2.2 Global Immunoglobulins Revenue by Application (2025-2030)
5.2.3 Global Immunoglobulins Revenue Market Share by Application (2019-2030)
5.3 Global Immunoglobulins Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Hualan Biological Engineering Inc.
6.1.1 Hualan Biological Engineering Inc. Corporation Information
6.1.2 Hualan Biological Engineering Inc. Description and Business Overview
6.1.3 Hualan Biological Engineering Inc. Immunoglobulins Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Hualan Biological Engineering Inc. Immunoglobulins Product Portfolio
6.1.5 Hualan Biological Engineering Inc. Recent Developments/Updates
6.2 Omrix Biopharmaceuticals Ltd.
6.2.1 Omrix Biopharmaceuticals Ltd. Corporation Information
6.2.2 Omrix Biopharmaceuticals Ltd. Description and Business Overview
6.2.3 Omrix Biopharmaceuticals Ltd. Immunoglobulins Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Omrix Biopharmaceuticals Ltd. Immunoglobulins Product Portfolio
6.2.5 Omrix Biopharmaceuticals Ltd. Recent Developments/Updates
6.3 Behring GmbH
6.3.1 Behring GmbH Corporation Information
6.3.2 Behring GmbH Description and Business Overview
6.3.3 Behring GmbH Immunoglobulins Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Behring GmbH Immunoglobulins Product Portfolio
6.3.5 Behring GmbH Recent Developments/Updates
6.4 Shanghai RAAS Blood Products
6.4.1 Shanghai RAAS Blood Products Corporation Information
6.4.2 Shanghai RAAS Blood Products Description and Business Overview
6.4.3 Shanghai RAAS Blood Products Immunoglobulins Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shanghai RAAS Blood Products Immunoglobulins Product Portfolio
6.4.5 Shanghai RAAS Blood Products Recent Developments/Updates
6.5 Option Care Enterprises
6.5.1 Option Care Enterprises Corporation Information
6.5.2 Option Care Enterprises Description and Business Overview
6.5.3 Option Care Enterprises Immunoglobulins Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Option Care Enterprises Immunoglobulins Product Portfolio
6.5.5 Option Care Enterprises Recent Developments/Updates
6.6 ADMA Biologics,
6.6.1 ADMA Biologics, Corporation Information
6.6.2 ADMA Biologics, Description and Business Overview
6.6.3 ADMA Biologics, Immunoglobulins Sales, Revenue and Gross Margin (2019-2024)
6.6.4 ADMA Biologics, Immunoglobulins Product Portfolio
6.6.5 ADMA Biologics, Recent Developments/Updates
6.7 BioScrip
6.6.1 BioScrip Corporation Information
6.6.2 BioScrip Description and Business Overview
6.6.3 BioScrip Immunoglobulins Sales, Revenue and Gross Margin (2019-2024)
6.4.4 BioScrip Immunoglobulins Product Portfolio
6.7.5 BioScrip Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Immunoglobulins Industry Chain Analysis
7.2 Immunoglobulins Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Immunoglobulins Production Mode & Process
7.4 Immunoglobulins Sales and Marketing
7.4.1 Immunoglobulins Sales Channels
7.4.2 Immunoglobulins Distributors
7.5 Immunoglobulins Customers
8 Immunoglobulins Market Dynamics
8.1 Immunoglobulins Industry Trends
8.2 Immunoglobulins Market Drivers
8.3 Immunoglobulins Market Challenges
8.4 Immunoglobulins Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
